Statement from the DEA regarding Electronic Prescribing before the Senate Judiciary Committee...BD
DEA is keenly aware that pharmaceutical controlled substances are vital tools for the medical community. DEA also is aware that various public and private entities are striving to leverage modern-day technology to streamline its business practices. DEA supports the responsible adoption of electronic prescriptions for controlled substances in a manner that will meet statutory obligations and minimize the risk of diversion. However, in the absence of appropriate controls, allowing electronic prescriptions for controlled substances would certainly exacerbate a growing epidemic of prescription drug abuse in the United States. It is essential that the rules governing the electronic prescribing of controlled substances do not undermine the ability of federal, state, and local law enforcement to identify and prosecute those who engage in diversion and put our citizens at risk.
It is critical that the technology and standards to be employed include adequate security that incorporates authentication, nonrepudiation, and integrity in the record keeping process. These three security-related elements are necessary to ensure that DEA can fulfill its obligations under the Controlled Substances Act (CSA).
DEA supports the use of technology to reduce medical errors, streamline the medical process and increase efficiency.
0 comments :
Post a Comment